Arkolith/Insider Trading/MIRM/Form 4

Howe Jolanda

SVP, GLOBAL CONTROLLERMirum Pharmaceuticals, Inc. (MIRM) · full profile →Form 4 · filed Feb 3, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$100K
Net Open-Market Flow
-$100K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 2, 2026Sell(S)968$103.30$100K5K
Jan 31, 2026Option exercise(M)2K——5K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 31, 2026Option exercise(M)2K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001974200-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML